华东医药
(000963)
| 流通市值：665.59亿 | | | 总市值：666.80亿 |
| 流通股本：17.51亿 | | | 总股本：17.54亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 4,739,290,249.11 | 5,650,547,127.07 | 3,563,064,869.46 | 4,663,378,011.64 |
| 衍生金融资产 | - | 16,488,136.54 | 16,409,129.45 | 16,434,493.97 |
| 应收票据及应收账款 | 9,959,874,617.5 | 7,975,907,427.49 | 9,677,692,232.29 | 7,462,062,780.8 |
| 其中：应收票据 | - | 11,341,351.13 | - | 6,812,089.97 |
| 应收账款 | 9,959,874,617.5 | 7,964,566,076.36 | 9,677,692,232.29 | 7,455,250,690.83 |
| 应收款项融资 | 615,997,329.9 | 1,659,103,759.04 | 843,257,932.3 | 1,434,366,300.69 |
| 预付款项 | 453,619,057.35 | 331,737,711.33 | 362,069,336.43 | 279,207,655.4 |
| 其他应收款合计 | 526,012,334.37 | 411,505,485.2 | 473,836,282.59 | 291,135,104.33 |
| 应收股利 | 223,608.84 | 223,608.84 | 2,623,608.84 | 2,623,608.84 |
| 存货 | 4,906,568,632.85 | 4,379,240,489.45 | 4,224,074,951.91 | 4,290,214,266.03 |
| 其他流动资产 | 52,102,427.05 | 81,397,040.52 | 51,878,760.17 | 59,881,757.08 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 21,253,464,648.13 | 20,505,927,176.64 | 19,212,283,494.6 | 18,496,680,369.94 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,504,680,048.89 | 1,540,257,326.17 | 1,529,526,141.05 | 1,535,907,809.85 |
| 其他权益工具投资 | 597,327,085.25 | 566,568,278.72 | 565,223,872.68 | 565,223,872.68 |
| 投资性房地产 | 12,056,372.93 | 12,270,841.77 | 12,485,783.85 | 12,746,181.87 |
| 固定资产 | 4,151,614,313.81 | 4,158,172,111.39 | 4,050,202,967.46 | 4,140,144,817.51 |
| 在建工程 | 956,356,801.65 | 918,366,234.28 | 927,713,584.81 | 913,147,212.17 |
| 使用权资产 | 163,209,658.39 | 157,318,875.96 | 139,021,674.64 | 151,175,007.16 |
| 无形资产 | 2,548,279,294.67 | 2,486,120,816.95 | 2,527,437,482.39 | 2,333,787,357.62 |
| 开发支出 | 1,220,784,671.74 | 1,149,241,824.64 | 1,068,480,143.55 | 992,532,091.86 |
| 商誉 | 2,909,064,173.67 | 2,591,744,585.15 | 2,596,809,693.91 | 2,598,696,062.31 |
| 长期待摊费用 | 21,569,252.06 | 19,756,292.05 | 19,291,856.38 | 20,053,854.34 |
| 递延所得税资产 | 232,727,968.46 | 233,149,891.4 | 187,808,574.44 | 187,808,574.44 |
| 其他非流动资产 | 1,924,119,435.95 | 1,827,889,520.52 | 1,631,559,010.61 | 1,561,458,605.23 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 16,241,789,077.47 | 15,660,856,599 | 15,255,560,785.77 | 15,012,681,447.04 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 37,495,253,725.6 | 36,166,783,775.64 | 34,467,844,280.37 | 33,509,361,816.98 |
| 流动负债: | | | | |
| 短期借款 | 1,833,368,155.46 | 1,405,140,132.05 | 1,083,597,089.07 | 822,380,292.37 |
| 应付票据及应付账款 | 7,623,754,972.93 | 6,975,514,379.96 | 5,764,029,117.04 | 6,102,253,940.25 |
| 其中：应付票据 | 2,766,860,378.77 | 2,184,117,028.14 | 1,437,934,424.82 | 1,727,420,960.3 |
| 应付账款 | 4,856,894,594.16 | 4,791,397,351.82 | 4,326,094,692.22 | 4,374,832,979.95 |
| 预收款项 | 1,707,483.62 | 1,732,122.7 | 405,231.33 | 1,393,551.48 |
| 合同负债 | 128,171,949.61 | 125,051,134.31 | 170,289,424.4 | 135,459,275.17 |
| 应付职工薪酬 | 208,737,763.77 | 213,405,220.46 | 215,396,862.69 | 359,148,474.25 |
| 应交税费 | 536,518,574.86 | 452,700,174.26 | 547,143,131.41 | 489,385,055.57 |
| 其他应付款合计 | 3,606,014,657.41 | 3,426,723,106.12 | 2,910,002,629.17 | 2,518,621,382.87 |
| 应付股利 | 143,024,219.6 | 146,258,219.6 | 143,024,219.6 | 143,024,219.6 |
| 一年内到期的非流动负债 | 378,428,427.31 | 683,210,855.71 | 209,413,662.46 | 359,342,623.38 |
| 其他流动负债 | 16,262,707.17 | 9,434,101.9 | 18,040,693.69 | 14,621,494.85 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 14,332,964,692.14 | 13,292,911,227.47 | 10,918,317,841.26 | 10,802,606,090.19 |
| 非流动负债: | | | | |
| 长期借款 | 67,979,467.42 | 81,565,510.08 | 519,383,524.08 | 520,759,460.07 |
| 租赁负债 | 88,779,151.93 | 69,083,110.73 | 83,006,313.46 | 56,695,158.59 |
| 长期应付款 | 24,144,309 | 25,507,681.65 | 24,805,289.23 | 107,251,248.59 |
| 预计负债 | 37,294,797 | 37,973,290.55 | 38,460,444.39 | 37,184,074.06 |
| 递延收益 | 147,307,332.45 | 158,889,475.61 | 167,391,739.98 | 171,056,435.34 |
| 递延所得税负债 | 180,093,287.69 | 173,389,997.24 | 182,493,233.05 | 184,373,974.04 |
| 其他非流动负债 | 46,192,650 | 46,192,650 | 46,192,650 | 47,170,650 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 591,790,995.49 | 592,601,715.86 | 1,061,733,194.19 | 1,124,491,000.69 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 14,924,755,687.63 | 13,885,512,943.33 | 11,980,051,035.45 | 11,927,097,090.88 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,754,262,548 | 1,754,327,548 | 1,754,327,548 | 1,754,425,348 |
| 资本公积 | 2,487,606,390.48 | 2,484,397,834.82 | 2,448,599,611 | 2,446,313,774.82 |
| 减:库存股 | 80,458,069.07 | 82,074,369.07 | 82,074,369.07 | 84,519,369.07 |
| 其他综合收益 | -22,665,647.88 | -46,627,046.46 | 247,990.92 | -40,341,544.18 |
| 盈余公积 | 1,277,779,972.18 | 1,277,779,972.18 | 1,277,779,972.18 | 1,277,779,972.18 |
| 未分配利润 | 16,624,852,605.71 | 16,372,490,548.27 | 16,556,363,135.87 | 15,693,951,574.91 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 22,041,377,799.42 | 21,760,294,487.74 | 21,955,243,888.9 | 21,047,609,756.66 |
| 少数股东权益 | 529,120,238.55 | 520,976,344.57 | 532,549,356.02 | 534,654,969.44 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 22,570,498,037.97 | 22,281,270,832.31 | 22,487,793,244.92 | 21,582,264,726.1 |
| 负债和股东权益合计 | 37,495,253,725.6 | 36,166,783,775.64 | 34,467,844,280.37 | 33,509,361,816.98 |
| 公告日期 | 2024-10-25 | 2024-08-16 | 2024-04-26 | 2024-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |